Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
August 27, 2001
- Majority of Patients Want to See Their Own Medical Records: JNA Survey
August 27, 2001
- Reform Promotion Headquarters Proposes Reform of Drug Organization
August 27, 2001
- Goldshield Group Plans Advances into Japanese Market
August 27, 2001
- Banyu, Kyorin to Launch LT Antagonist
August 27, 2001
- Ceiling on Natural Increase in Social Security-related Budget Set at \700 Bil.
August 27, 2001
- Further Deregulation Needed for Nutritional Supplements: US Embassy Tokyo
August 27, 2001
- Korosho Prepares for Full Discussions on Healthcare Reform from September
August 27, 2001
- Kao Develops New Ingredients Effective against Wrinkles
August 27, 2001
- Korosho Asks Bayer, Takeda to Take Safety Measures Regarding Cerivastatin
August 27, 2001
- Efco, Kyuyukai Postpone Merger to Next Fiscal Year
August 27, 2001
- Korosho to Listen to Industry's Opinions on Amending PAL
August 27, 2001
- Pharmacists Are Absent from 64% of Stores Selling Drugs at Night
August 27, 2001
- Price Adjustment Method No Longer Functions Properly: Mr Fujii, New Diet Member
August 27, 2001
- OCT NEWS IN BRIEF
August 27, 2001
- Economic Reform Should Not Affect Quality of Social Security Services: Mr Takemi, Lower House Member
August 27, 2001
- Yamanouchi Discovers Immunocompetent Cell Activating Gene
August 27, 2001
- Innovex to Establish Japan's 1st MR Syndicate Team Next Year: Mr Feldman
August 27, 2001
- Stage 2 Schedule Set for Quality Reevaluation of 249 Ingredients
August 27, 2001
- Genomic Analysis by Industry, Government, Academia Started
August 27, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…